Joseph R Triggs1, Amanda J Krause2, Dustin A Carlson2, Erica N Donnan2, Ryan A J Campagna3, Anand S Jain4, Peter J Kahrilas2, Eric S Hungness3, John E Pandolfino2. 1. Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 2. Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. 3. Division of Gastrointestinal Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. 4. Division of Gastroenterology and Hepatology, Emory University School of Medicine, Atlanta, Georgia, USA.
Abstract
BACKGROUND AND AIMS: Although laparoscopic Heller myotomy (LHM) or peroral endoscopic myotomy (POEM) is highly effective, 10% to 20% of patients with achalasia remain symptomatic after treatment. In evaluating such patients, we have observed a pattern of failure associated with a pseudodiverticulum, or blown-out myotomy (BOM), in the distal esophagus. We aimed to assess risk factors and patient-reported outcomes associated with a BOM. METHODS: We reviewed our manometry database for patients with achalasia previously treated with LHM or POEM. We included patients who had a post-treatment esophagram within 1 year of their follow-up manometry. A BOM was defined radiographically as a wide-mouthed outpouching (>50% increase in esophageal diameter) in the area of the myotomy. RESULTS: One hundred twenty-nine patients with achalasia who underwent treatment were included; 23 (17.8%) had a BOM. Comparing patients with a BOM with those without, post-treatment Eckardt scores were significantly greater (5 vs 2, P = .002), type III achalasia was more common (39.1% vs 14.2%, P = .005), and LHM was more common than POEM (73.9% vs 26.1%, P = .013). The integrated relaxation pressure was also significantly greater in the BOM group (15.0 mm Hg vs 11.0 mm Hg, P = .025). CONCLUSIONS: BOM is a common adverse event after myotomy for achalasia but is not seen after pneumatic dilation. Pretreatment type III achalasia, LHM as opposed to POEM, and a greater post-treatment integrated relaxation pressure were risk factors for developing a BOM. We speculate that esophageal wall strain in the area weakened by myotomy, whether from residual spastic contractility or continued esophageal outflow obstruction, may be the underlying mechanism of BOM development.
BACKGROUND AND AIMS: Although laparoscopic Heller myotomy (LHM) or peroral endoscopic myotomy (POEM) is highly effective, 10% to 20% of patients with achalasia remain symptomatic after treatment. In evaluating such patients, we have observed a pattern of failure associated with a pseudodiverticulum, or blown-out myotomy (BOM), in the distal esophagus. We aimed to assess risk factors and patient-reported outcomes associated with a BOM. METHODS: We reviewed our manometry database for patients with achalasia previously treated with LHM or POEM. We included patients who had a post-treatment esophagram within 1 year of their follow-up manometry. A BOM was defined radiographically as a wide-mouthed outpouching (>50% increase in esophageal diameter) in the area of the myotomy. RESULTS: One hundred twenty-nine patients with achalasia who underwent treatment were included; 23 (17.8%) had a BOM. Comparing patients with a BOM with those without, post-treatment Eckardt scores were significantly greater (5 vs 2, P = .002), type III achalasia was more common (39.1% vs 14.2%, P = .005), and LHM was more common than POEM (73.9% vs 26.1%, P = .013). The integrated relaxation pressure was also significantly greater in the BOM group (15.0 mm Hg vs 11.0 mm Hg, P = .025). CONCLUSIONS: BOM is a common adverse event after myotomy for achalasia but is not seen after pneumatic dilation. Pretreatment type III achalasia, LHM as opposed to POEM, and a greater post-treatment integrated relaxation pressure were risk factors for developing a BOM. We speculate that esophageal wall strain in the area weakened by myotomy, whether from residual spastic contractility or continued esophageal outflow obstruction, may be the underlying mechanism of BOM development.
Authors: Anand S Jain; Dustin A Carlson; Joseph Triggs; Michael Tye; Wenjun Kou; Ryan Campagna; Eric Hungness; Donald Kim; Peter J Kahrilas; John E Pandolfino Journal: Am J Gastroenterol Date: 2019-09 Impact factor: 10.864
Authors: David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce Reeve; Susan Yount; Dagmar Amtmann; Rita Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert Devellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul Pilkonis; Dennis Revicki; Matthias Rose; Kevin Weinfurt; Ron Hays Journal: J Clin Epidemiol Date: 2010-08-04 Impact factor: 6.437
Authors: Froukje B van Hoeij; Fraukje A Ponds; Yuki Werner; Joel M Sternbach; Paul Fockens; Barbara A Bastiaansen; André J P M Smout; John E Pandolfino; Thomas Rösch; Albert J Bredenoord Journal: Gastrointest Endosc Date: 2017-05-03 Impact factor: 9.427
Authors: Dustin A Carlson; Zhiyue Lin; Peter J Kahrilas; Joel Sternbach; Eric S Hungness; Nathaniel J Soper; Michelle Balla; Zoe Listernick; Michael Tye; Katherine Ritter; Jenna Craft; Jody D Ciolino; John E Pandolfino Journal: Am J Gastroenterol Date: 2016-10-04 Impact factor: 10.864
Authors: Sourav Halder; Shashank Acharya; Wenjun Kou; Ryan A J Campagna; Joseph R Triggs; Dustin A Carlson; Abdul Aziz Aadam; Eric S Hungness; Peter J Kahrilas; John E Pandolfino; Neelesh A Patankar Journal: Am J Physiol Gastrointest Liver Physiol Date: 2022-02-16 Impact factor: 4.052